Tango Therapeutics, Inc. · NASDAQ:TNGX
Lee Sung received 570 Tango Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 5, 2026 · Filed Jun 8, 2026
On Jun 5, 2026, Lee Sung (Director) received 570 Tango Therapeutics, Inc. shares as an award, leaving 22,870 shares. Filed Jun 8, 2026 (Form 4).
- Awarded
- 570 shares
- Holding after
- 22,870 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 570 | 22,870 | Direct |
Source
Related
- Tango Therapeutics, Inc.
- Lee Sung
- Tango Therapeutics, Inc. shareholders
- Form 4 · Lee Sung · May 1, 2026
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026